Articles by Edgar V. Lerma, MD

This supplement was supported by AstraZeneca.

Prevalence, Resource Utilization, and Economic Impact of Kidney Function and Proteinuria in Patients With Focal Segmental Glomerulosclerosis
ByMark E. Bensink, PhD,Kamlesh M. Thakker, BPharm, PhD,Edgar V. Lerma, MD,Richard M. Lieblich, RPh,C. Martin Bunke, MD,Kaijun Wang, PhD,Wu Gong, MS,Andrew Rava, MPH,Michael V. Murphy, BA,David Oliveri, BS,Diana T. Amari, PhD,David Cork, PhD,Juan Carlos Q. Velez, MD